K Kuroda
Antimicrobial peptide FF/CAP18 induces apoptotic cell death in HCT116 colon cancer cells via changes in the metabolic profile
Kuroda, K; Fukuda, T; Isogai, H; Okumura K, K; Krstic-Demonacos, M; Isogai, E
Authors
T Fukuda
H Isogai
K Okumura K
Prof Marija Krstic-Demonacos M.Krstic-Demonacos@salford.ac.uk
Professor
E Isogai
Abstract
Metabolic reprogramming is one of the hallmarks of cancer and can be targeted by therapeutic agents. We previously reported that cathelicidin-related or modified antimicrobial peptides, such as FF/CAP18, have antiproliferative effects on the squamous cell carcinoma cell line SAS-H1, and the colon carcinoma cell line HCT116. Although antimicrobial peptides have potential use in the development of new therapeutic strategies, their effects on the metabolism of cancer cells are poorly understood. Here, we investigated changes in the levels of metabolites in HCT116 cells caused by FF/CAP18, via capillary electrophoresis time-of-flight mass spectrometry (CE-TOFMS). Analysis of the 177 intracellular metabolites and 113 metabolites in conditioned medium that were detected by CE-TOFMS, revealed dramatic changes in the metabolic profile of HCT116 cells after treatment with FF/CAP18. The metabolic profile showed that the levels of most metabolites in the major metabolic pathways supported the rapid proliferation of cancer cells. Purine metabolism, glycolysis, and the TCA cycle, were altered in FF/CAP18-treated cells in a dose-dependent manner. Our present study provides mechanistic insights into the anticancer effects of antimicrobial peptides that show great potential as new therapies for colon cancer.
Citation
Kuroda, K., Fukuda, T., Isogai, H., Okumura K, K., Krstic-Demonacos, M., & Isogai, E. (2015). Antimicrobial peptide FF/CAP18 induces apoptotic cell death in HCT116 colon cancer cells via changes in the metabolic profile. International Journal of Oncology, 46(4), 1516-1526. https://doi.org/10.3892/ijo.2015.2887
Journal Article Type | Article |
---|---|
Acceptance Date | Jan 30, 2015 |
Online Publication Date | Feb 10, 2015 |
Publication Date | Feb 10, 2015 |
Deposit Date | Apr 27, 2015 |
Publicly Available Date | Apr 5, 2016 |
Journal | International Journal of Oncology |
Print ISSN | 1019-6439 |
Electronic ISSN | 1791-2423 |
Publisher | Spandidos Publications |
Peer Reviewed | Peer Reviewed |
Volume | 46 |
Issue | 4 |
Pages | 1516-1526 |
DOI | https://doi.org/10.3892/ijo.2015.2887 |
Publisher URL | http://dx.doi.org/10.3892/ijo.2015.2887 |
Additional Information | Projects : N/A Grant Number: N/A |
Files
ijo_46_4_1516_PDF.pdf
(1.2 Mb)
PDF
Licence
http://creativecommons.org/licenses/by-nc/3.0/
Publisher Licence URL
http://creativecommons.org/licenses/by-nc/3.0/
You might also like
Investigation of P53 and TTC5 function in lung cancer
(2024)
Thesis
Targeting Transcriptional CDKs in Medulloblastoma
(2024)
Thesis
Evaluation of Novel Diketones as Anti-cancer Agents
(2024)
Thesis
Intratumor microbiota as a novel potential prognostic indicator in mesothelioma
(2023)
Journal Article
Elimination of Off-Target Effect by Chemical Modification of 5'-End of Small Interfering RNA
(2022)
Journal Article
Downloadable Citations
About USIR
Administrator e-mail: library-research@salford.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search